Keyphrases
Allogeneic
100%
Hematopoietic Stem Cell Transplantation
100%
Combined Strategy
100%
Donor Lymphocyte Infusion
100%
Hematopoietic chimerism
100%
Graft-versus-host Disease (GvHD)
40%
Donor Cells
40%
Cell Engraftment
40%
H-2Kb
40%
Mixed Hematopoietic chimerism
40%
Cell Therapy
20%
Murine Model
20%
Organ Transplantation
20%
Fetus
20%
Clinical Application
20%
Immunosuppression
20%
Peripheral Blood
20%
Bone Marrow Cells
20%
High Dose
20%
Intraperitoneal Injection
20%
Tolerance Induction
20%
Genetic Disease
20%
Donor-specific Tolerance
20%
Splenocytes
20%
Dose Effect
20%
Potential Treatments
20%
Potential Therapeutic Strategies
20%
Day 14
20%
Cell Donors
20%
Congenic
20%
T Cell Depletion
20%
Targeted Immunotherapy
20%
Complex Barriers
20%
CD45
20%
Donor chimerism
20%
Mixed chimerism
20%
Major Histocompatibility Complex
20%
Therapeutic Levels
20%
Minimal Risk
20%
Cytoreductive Surgery
20%
Blood chimerism
20%
Medicine and Dentistry
Chimera
100%
Donor Lymphocyte Infusion
100%
in Utero Stem Cell Transplantation
100%
Engraftment
33%
Graft Versus Host Reaction
33%
Diseases
16%
Transplantation
16%
Immunosuppressive Treatment
16%
Genetic Disorder
16%
Drug Megadose
16%
Cell Therapy
16%
Organ Transplantation
16%
Intraperitoneal Drug Administration
16%
Conditioning
16%
T Cell
16%
Immunotherapy
16%
Bone Marrow Cell
16%
Major Histocompatibility Complex
16%
Immunology and Microbiology
Chimera
100%
in Utero Stem Cell Transplantation
100%
Lymphocyte
100%
Graft-Versus-Host Disease
33%
Engraftment
33%
Splenocyte
16%
Organ Transplantation
16%
Immunosuppression
16%
Bone Marrow Cell
16%
Conditioning
16%
Drug Megadose
16%
Major Histocompatibility Complex
16%
Immunotherapy
16%
T Cell
16%
Biochemistry, Genetics and Molecular Biology
Chimera
100%
in Utero Stem Cell Transplantation
100%
Lymphocyte
100%
Host
33%
Major Histocompatibility Complex
16%
Congenic
16%
Genetic Disorder
16%
Conditioning
16%
Drug Megadose
16%
T Cell
16%
Splenocyte
16%